Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.

Cancer Cell
Huimin GengMarkus Müschen

Abstract

Studying 830 pre-B ALL cases from four clinical trials, we found that human ALL can be divided into two fundamentally distinct subtypes based on pre-BCR function. While absent in the majority of ALL cases, tonic pre-BCR signaling was found in 112 cases (13.5%). In these cases, tonic pre-BCR signaling induced activation of BCL6, which in turn increased pre-BCR signaling output at the transcriptional level. Interestingly, inhibition of pre-BCR-related tyrosine kinases reduced constitutive BCL6 expression and selectively killed patient-derived pre-BCR(+) ALL cells. These findings identify a genetically and phenotypically distinct subset of human ALL that critically depends on tonic pre-BCR signaling. In vivo treatment studies suggested that pre-BCR tyrosine kinase inhibitors are useful for the treatment of patients with pre-BCR(+) ALL.

References

Apr 23, 2003·Immunity·Edina SchweighofferVictor L J Tybulewicz
Jan 25, 2007·Blood·Mrinmoy SanyalMichael L Cleary
Nov 3, 2009·Cell·Lakshmi SrinivasanKlaus Rajewsky
Jan 2, 2010·Molecular Cancer·Jiyuan KeSubbarao Bondada
May 26, 2010·The Journal of Experimental Medicine·Cihangir DuyMarkus Müschen
Sep 2, 2011·The Journal of Biological Chemistry·Li WangKehao Zhao
Mar 2, 2013·Nature Reviews. Drug Discovery·Ryan M Young, Louis M Staudt
Jun 21, 2013·The New England Journal of Medicine·Michael L WangKristie A Blum
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Jul 26, 2013·Nature Reviews. Immunology·Robert C Rickert
Sep 27, 2013·The New England Journal of Medicine·John C ByrdDanelle F James
Jan 24, 2014·The New England Journal of Medicine·Ajay K GopalGilles A Salles
Mar 20, 2014·Nature Reviews. Clinical Oncology·Jan A Burger, Klaus Okkenhaug

❮ Previous
Next ❯

Citations

Feb 3, 2016·The Journal of Experimental Medicine·Jeffrey J BednarskiBarry P Sleckman
Mar 12, 2015·Cancer Cell·Thomas Trimarchi, Iannis Aifantis
Aug 25, 2015·The Journal of Clinical Investigation·Terry J Fry, Peter D Aplan
Aug 25, 2015·The Journal of Clinical Investigation·Jesús Duque-AfonsoMichael L Cleary
Oct 30, 2016·Experimental Hematology·Robin R WeidemannAlexander Gerbaulet
Mar 28, 2018·Journal of Experimental & Clinical Cancer Research : CR·Helicia PazNora Heisterkamp
Sep 22, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Renato BassanSabina Chiaretti
Dec 21, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cheng PengChuanxin Huang
Mar 16, 2019·Immunological Reviews·Stefano CasolaFabio Facchetti
Jan 6, 2018·Nature Reviews. Cancer·Markus Müschen
Feb 22, 2017·The EMBO Journal·Leonie SmeenkMeinrad Busslinger
Aug 10, 2019·Genes & Development·Christian HurtzMarkus Müschen
Feb 28, 2020·Cells·Oriol de BarriosMaribel Parra
Oct 5, 2018·BMC Cancer·Kar-Tong TanH Phillip Koeffler
Sep 29, 2019·Pharmacological Reviews·Peter J Houghton, Raushan T Kurmasheva
Dec 22, 2017·Expert Opinion on Therapeutic Targets·Rebecca J Leeman-Neill, Govind Bhagat
Nov 8, 2019·Blood Advances·Juan Carlos Rivera-MuliaDavid M Gilbert
Mar 4, 2017·Blood·Ilaria Iacobucci
Aug 19, 2017·Cellular and Molecular Life Sciences : CMLS·Camille Malouf, Katrin Ottersbach
Mar 20, 2020·The Journal of Clinical Investigation·Christian HurtzSarah K Tasian
Feb 12, 2017·Acta Paediatrica·Olli Lohi, Merja Heinäniemi
Oct 21, 2016·Cancer Research·Jesús Duque-AfonsoMichael L Cleary
Sep 29, 2018·Cancer Research·Jesús Duque-AfonsoMichael L Cleary

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.